Found 402 matching trials
Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer
PHASE1RATIONALE: Vaccines may help the body build an effective immune response to...
Location
University of Pittsburgh Cancer Institute
Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).
PHASE1This Phase I/IIa clinical study is testing an experimental treatment called...
Location
Hospital Clínic de Barcelona
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT
PHASE1The purposes of the study are to determine the maximum tolerated dose (MTD)...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
PHASE1The research objective is to evaluate the safety and tolerability of the in...
Location
Hebei Provincial Center for Disease Control and Prevention
Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
PHASE1This is a Phase 1 open-label, multicenter study of the safety and tolerabil...
Location
City of Hope Medical Center
Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies
EARLY_PHASE1Current treatments for relapsed/refractory hematopoietic malignancies such ...
Location
Multiple Locations
Safety Study of Adjuvant Vaccine to Treat Melanoma Patients
PHASE1The incidence of melanoma is increasing with an estimated incidence of 59,9...
Location
New York University Langone Medical Center
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation
PHASE1This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
PHASE2This experiment will test the safety and effectiveness of a treatment for m...
Location
National Cancer Institute (NCI)
Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia
PHASE1This is an open label, multicenter Phase 1 study to determine the MTD, dosi...
Location
Comprehensive Cancer Center (UAB CCC)